Suppr超能文献

人离体肾肾小球中的血管紧张素 II 受体。

Angiotensin II receptors in human isolated renal glomeruli.

作者信息

Chansel D, Ardaillou N, Nivez M P, Ardaillou R

出版信息

J Clin Endocrinol Metab. 1982 Nov;55(5):961-6. doi: 10.1210/jcem-55-5-961.

Abstract

125I-Labeled angiotensin II ([125I]A II) binds specifically to glomeruli isolated from human kidneys that were obtained at nephrectomy or early autopsy. Equilibrium was reached after 30 min, and specific binding represented more than 90% of the total binding. Dissociation after dilution with the addition of an excess of unlabeled hormone was more rapid than after dilution alone. The effect increased as a function of the A II concentration. The Scatchard plot derived from saturation experiments was curvilinear, with an upward concavity. Two groups of receptor sites could be defined by the Kd values (0.1 and 2 nM, respectively) and the number of receptor sites (40 and 300 fmol mg glomerular protein-1, respectively). Alternatively, binding could be considered to follow a negative cooperative type of hormone-receptor interaction. [Asn1, Val5]A II, [Asp1,Ile5]A II, [des, Asp1,Ile5]A II, [Sar1, Ala8]A II, and [Sar1, Ile8]A II were all equally effective as competitive inhibitors of [125I]A II binding. Both calcium and magnesium (0.5-5 mM) produced an increase in [125I]A II specific binding, whereas guanylylimidodiphosphate, an analog of GTP, inhibited it. Degradation of the [125I]A II present in the incubation medium was estimated by three different techniques. It increased linearly with time and reached 20% at 30 min. Specific binding of A II to human glomeruli at plasma concentrations observed in man under physiological conditions and during the iv administration of A II demonstrates that human renal glomeruli include target cells for A II and thus suggests a role for A II in regulation of the glomerular filtration rate in man.

摘要

125I标记的血管紧张素II([125I]A II)能特异性结合从肾切除或早期尸检获得的人肾中分离出的肾小球。30分钟后达到平衡,特异性结合占总结合的90%以上。加入过量未标记激素稀释后的解离比单独稀释后的解离更快。这种效应随A II浓度的增加而增强。饱和实验得到的Scatchard图呈曲线,向上凹陷。根据解离常数(分别为0.1和2 nM)和受体位点数量(分别为40和300 fmol mg肾小球蛋白-1)可定义两组受体位点。或者,可以认为结合遵循激素-受体相互作用的负协同类型。[Asn1, Val5]A II、[Asp1,Ile5]A II、[des, Asp1,Ile5]A II、[Sar1, Ala8]A II和[Sar1, Ile8]A II作为[125I]A II结合的竞争性抑制剂均具有同等效力。钙和镁(0.5 - 5 mM)均使[125I]A II特异性结合增加,而GTP类似物鸟苷酰亚胺二磷酸则抑制其结合。通过三种不同技术估算了孵育介质中[125I]A II的降解情况。其随时间呈线性增加,30分钟时达到20%。在生理条件下以及静脉注射A II期间,人血浆浓度下A II与人肾小球的特异性结合表明,人肾小球包含A II的靶细胞,因此提示A II在调节人肾小球滤过率中发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验